In the BioHarmony Drug Report Database

"Preview" Icon

Repaglinide

Prandin, NovoNorm (repaglinide) is a small molecule pharmaceutical. Repaglinide was first approved as Prandin on 1997-12-22. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus. The pharmaceutical is active against ATP-binding cassette sub-family C member 8.

 

Trade Name

 

NovoNorm, Prandin
 

Common Name

 

repaglinide
 

ChEMBL ID

 

CHEMBL1272
 

Indication

 

type 2 diabetes mellitus
 

Drug Class

 

Antidiabetic, SGLT2 inhibitors, not phlorozin derivatives

Image (chem structure or protein)

Repaglinide structure rendering